Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Advanced stage leiomyosarcoma (LMS) is incurable with current systemic antitumor therapies. Therefore, there is clinical interest in exploring novel therapeutic regimens to treat LMS. We reviewed the medical records of 75 consecutive patients with histologically confirmed metastatic LMS, who had bee...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Wang, Zhijie, Shi, Naiyi, Naing, Aung, Janku, Filip, Subbiah, Vivek, Araujo, Dejka M., Patel, Shreyaskumar R., Ludwig, Joseph A., Ramondetta, Lois M., Levenback, Charles F., Ramirez, Pedro T., Piha‐Paul, Sarina A., Hong, David, Karp, Daniel D., Tsimberidou, Apostolia M., Meric‐Bernstam, Funda, Fu, Siqing
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://ncbi.nlm.nih.gov/pubmed/27882721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.956
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi